Latest filings (excl ownership)
15-12G
Securities registration termination
20 Jun 23
EFFECT
Notice of effectiveness
9 Jun 23
EFFECT
Notice of effectiveness
9 Jun 23
EFFECT
Notice of effectiveness
9 Jun 23
25-NSE
Exchange delisting
8 Jun 23
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Jun 23
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Jun 23
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Jun 23
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Jun 23
POS AM
Prospectus update (post-effective amendment)
8 Jun 23
POS AM
Prospectus update (post-effective amendment)
8 Jun 23
SC 13E3/A
Going private transaction (amended)
8 Jun 23
SC TO-T/A
Third party tender offer statement (amended)
8 Jun 23
POS AM
Prospectus update (post-effective amendment)
8 Jun 23
8-K
Termination of a Material Definitive Agreement
8 Jun 23
SC 14D9/A
Tender offer solicitation (amended)
8 Jun 23
SC 13E3/A
Going private transaction (amended)
8 Jun 23
SC 13E3/A
Going private transaction (amended)
30 May 23
SC 14D9/A
Tender offer solicitation (amended)
30 May 23
SC 13E3/A
Going private transaction (amended)
26 May 23
SC TO-T/A
Third party tender offer statement (amended)
26 May 23
SC 13E3/A
Going private transaction (amended)
24 May 23
SC 14D9/A
Tender offer solicitation (amended)
24 May 23
CORRESP
Correspondence with SEC
24 May 23
UPLOAD
Letter from SEC
23 May 23
UPLOAD
Letter from SEC
23 May 23
SC 13E3/A
Going private transaction (amended)
18 May 23
SC 14D9/A
Tender offer solicitation (amended)
18 May 23
8-K
January 2024 PDUFA date expected
18 May 23
10-Q
2023 Q1
Quarterly report
11 May 23
SC 13E3
Going private transaction
5 May 23
SC 14D9
Tender offer solicitation
5 May 23
SC 13E3
Going private transaction
5 May 23
SC TO-T
Third party tender offer statement
5 May 23
8-K
Other Events
3 May 23
10-K/A
2022 FY
Annual report (amended)
28 Apr 23
SC14D9C
Written communication relating to third party tender offer
17 Apr 23
8-K
SNBL to Acquire Satsuma Pharmaceuticals
17 Apr 23
SC TO-C
Information about tender offer
17 Apr 23
10-K
2022 FY
Annual report
28 Mar 23
Latest ownership filings
SC 13G/A
BML Investment Partners, L.P.
13 Jun 23
4
Peter Kolchinsky
12 Jun 23
SC 13D/A
RA CAPITAL MANAGEMENT, L.P.
12 Jun 23
4
Thomas P. O'Neil
8 Jun 23
4
Rajeev M. Shah
8 Jun 23
4
KEN TAKANASHI
8 Jun 23
4
Michael T Riebe
8 Jun 23
4
Elisabeth Sandoval
8 Jun 23
4
Thomas P Soloway
8 Jun 23
4
John A Kollins
8 Jun 23
4
Heath Lukatch
8 Jun 23
4
THOMAS BRAXTON KING
8 Jun 23
4
Change in insider ownership
8 Jun 23
4
Mutya Harsch
8 Jun 23
SC 13D/A
Shin Nippon Biomedical Laboratories, Ltd.
8 Jun 23
SC 13D/A
Growth Equity Opportunities 17, LLC
2 May 23
SC 13D/A
RA CAPITAL MANAGEMENT, L.P.
18 Apr 23
SC 13D/A
Shin Nippon Biomedical Laboratories, Ltd.
17 Apr 23
SC 13G/A
SAMLYN CAPITAL, LLC
14 Feb 23
SC 13G/A
TPG GP A, LLC
10 Feb 23
SC 13G/A
BML Investment Partners, L.P.
8 Feb 23
SC 13D/A
Growth Equity Opportunities 17, LLC
27 Jan 23
4/A
KEN TAKANASHI
9 Dec 22
4
Braden Michael Leonard
23 Nov 22
SC 13G
BML Investment Partners, L.P.
16 Nov 22
4
Braden Michael Leonard
16 Nov 22
SC 13G/A
COMMODORE CAPITAL LP
16 Nov 22
4
Change in insider ownership
16 Nov 22
3
Braden Michael Leonard
16 Nov 22
4
Thomas P. O'Neil
7 Jun 22
4
DETLEF ALBRECHT
7 Jun 22
4
John A Kollins
7 Jun 22
4
Heath Lukatch
7 Jun 22
4
Elisabeth Sandoval
7 Jun 22
4
KEN TAKANASHI
7 Jun 22
4
Mutya Harsch
7 Jun 22
4
Thomas P Soloway
7 Jun 22
4
THOMAS BRAXTON KING
7 Jun 22
4
Michael T Riebe
7 Jun 22
4
Peter Kolchinsky
7 Jun 22